AxoGen (AXGN) Tops Q2 EPS by 9c; Reaffirms FY22 Guidance
Get Alerts AXGN Hot Sheet
Join SI Premium – FREE
AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.06), $0.09 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $34.5 million versus the consensus estimate of $33.82 million.
GUIDANCE:
AxoGen sees FY2022 revenue of $135-142 million, versus the consensus of $139.3 million.
For earnings history and earnings-related data on AxoGen (AXGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
- Gates Industrial Corporation plc (GTES) Tops Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share